These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 36292757)
1. Episomes and Transposases-Utilities to Maintain Transgene Expression from Nonviral Vectors. Kreppel F; Hagedorn C Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292757 [TBL] [Abstract][Full Text] [Related]
2. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839 [TBL] [Abstract][Full Text] [Related]
3. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye. Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652 [TBL] [Abstract][Full Text] [Related]
4. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy. Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480 [TBL] [Abstract][Full Text] [Related]
5. Applications of Sleeping Beauty transposons for nonviral gene therapy. Liu H; Visner GA IUBMB Life; 2007 Jun; 59(6):374-9. PubMed ID: 17613167 [TBL] [Abstract][Full Text] [Related]
6. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene. Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635 [TBL] [Abstract][Full Text] [Related]
7. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells. Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154 [TBL] [Abstract][Full Text] [Related]
8. Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological Overview. Prommersberger S; Monjezi R; Shankar R; Schmeer M; Hudecek M; Ivics Z; Schleef M Methods Mol Biol; 2022; 2521():25-39. PubMed ID: 35732991 [TBL] [Abstract][Full Text] [Related]
10. Design of a nonviral vector for site-selective, efficient integration into the human genome. Kaminski JM; Huber MR; Summers JB; Ward MB FASEB J; 2002 Aug; 16(10):1242-7. PubMed ID: 12153992 [TBL] [Abstract][Full Text] [Related]
11. Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Peng PD; Cohen CJ; Yang S; Hsu C; Jones S; Zhao Y; Zheng Z; Rosenberg SA; Morgan RA Gene Ther; 2009 Aug; 16(8):1042-9. PubMed ID: 19494842 [TBL] [Abstract][Full Text] [Related]
12. A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase. Ehrhardt A; Xu H; Huang Z; Engler JA; Kay MA Mol Ther; 2005 May; 11(5):695-706. PubMed ID: 15851008 [TBL] [Abstract][Full Text] [Related]
13. Nonviral gene delivery with the sleeping beauty transposon system. Ivics Z; Izsvák Z Hum Gene Ther; 2011 Sep; 22(9):1043-51. PubMed ID: 21867398 [TBL] [Abstract][Full Text] [Related]
14. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors. Mazda O Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722 [TBL] [Abstract][Full Text] [Related]
15. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381 [TBL] [Abstract][Full Text] [Related]